Wikidata

(Q62040994)

English

Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
A Phase 1/2 Multi-Center, Open Label, Dose Escalation Study to Determine the RP2D, Safety and Efficacy of GSK2857916 in Combination With Pomalidomide and Low-Dose Dexamethasone in Subjects With Relapsed and/or Refractory Multiple Myeloma (English)
0 references
start time
1 December 2018
0 references
end time
1 June 2023
0 references
number of participants
52
0 references
research intervention
(RS)-cyclophosphamide
0 references
dexamethasone acetate
0 references
pomalidomide
0 references
thalidomide
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62040994&oldid=2148522691"